Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04678362
Title TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma (TALASUR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Francois Baclesse

ureter transitional cell carcinoma

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma


Avelumab + Talazoparib

Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.